Einloggen
Einloggen
Oder einloggen mit
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Registrieren
Oder einloggen mit
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

EMERGENT BIOSOLUTIONS INC.

(A0LC2W)
  Bericht
ÜbersichtKurseChartsNewsRatingsTermineUnternehmenFinanzenAnalystenschätzungenRevisionenDerivateFonds 
ÜbersichtAlle NewsAnalystenempfehlungenAndere SprachenPressemitteilungenOffizielle PublikationenBranchen-News
Nachrichten in anderen Sprachen über EMERGENT BIOSOLUTIONS INC.
06.12.U.S. FDA grants priority review for Emergent's OTC opioid drug
06.12.Sector Update: Health Care Stocks are Mixed Premarket Tuesday
06.12.Emergent Biosolutions Inc. : Regulation FD Disclosure, Financial Statements and Exhibits (..
06.12.Emergent BioSolutions Says US FDA Accepts, Grants Priority Review for Over-the-Counter ..
06.12.Emergent BioSolutions Announces U.S. FDA Acceptance and Priority Review of Supplemental..
06.12.Emergent BioSolutions Inc. Announces U.S. FDA Acceptance and Priority Review of Supplem..
16.11.SAB Biotherapeutics Provides Company Update for Q3 2022 Financial Results
14.11.Emergent BioSolutions Receives Department of Defense Award to Evaluate Chikungunya Vacc..
14.11.Emergent BioSolutions Receives Department of Defense Award to Evaluate Chikungunya Vacc..
11.11.North American Morning Briefing: Fed Hopes, China -3-
11.11.Emergent BioSolutions Inc.'s Equity Buyback announced on November 11, 2021, has expired..
09.11.Health Care Down on Inflation Resilience -- Health Care Roundup
09.11.Emergent Biosolutions Q3 Adjusted Loss Widens, Revenue Falls; Cuts Full-Year Revenue Ou..
09.11.Tranche Update on Emergent BioSolutions Inc.'s Equity Buyback Plan announced on Novembe..
09.11.Emergent Biosolutions : Q3 Earnings Snapshot
08.11.Emergent Biosolutions Inc. : Results of Operations and Financial Condition, Regulation FD ..
08.11.Earnings Flash (EBS) EMERGENT BIOSOLUTIONS Reports Q3 Loss $-1.27
08.11.Earnings Flash (EBS) EMERGENT BIOSOLUTIONS Reports Q3 Revenue $240M
08.11.Emergent BioSolutions Reports Financial Results For Third Quarter 2022
08.11.Emergent BioSolutions Inc. Revises Earnings Guidance for the Year 2022
08.11.Emergent BioSolutions Inc. Reports Earnings Results for the Third Quarter and Nine Mont..
08.11.Earnings Reaction History: Emergent Biosolutions Inc, 62.5% Fo..
01.11.Emergent BioSolutions Presents Data from Phase 2 Study Evaluating Safety and Immunogeni..
01.11.Emergent BioSolutions Presents Data from Phase 2 Study Evaluating Safety and Immunogeni..
01.11.Emergent BioSolutions Inc. Presents Data from Phase 2 Study Evaluating Safety and Immun..
27.10.SAB Biotherapeutics Announces Exclusive Manufacturing Partnership with Emergent BioSolu..
27.10.SAB Biotherapeutics Announces Exclusive Manufacturing Partnership with Emergent BioSolu..
18.10.Emergent BioSolutions to Release Third Quarter 2022 Financial Results and Conduct Confe..
18.10.Emergent BioSolutions to Release Third Quarter 2022 Financial Results and Conduct Confe..
12.10.Around 12+ key companies are developing the Marburg Virus Disease Therapies | DelveInsi..
27.09.Emergent BioSolutions Completes Acquisition of Exclusive Worldwide Rights to TEMBEXA, t..
26.09.Emergent Biosolutions Inc. : Completion of Acquisition or Disposition of Assets, Regulatio..
26.09.Emergent BioSolutions Completes Acquisition of Rights to Smallpox Oral Antiviral Tembex..
26.09.Emergent BioSolutions Completes Acquisition of Exclusive Worldwide Rights to TEMBEXA® (..
26.09.Emergent BioSolutions Completes Acquisition of Exclusive Worldwide Rights to TEMBEXA® (..
26.09.Emergent BioSolutions Inc. completed the acquisition of Exclusive Worldwide Rights to B..
19.09.Gamida Cell Appoints Abigail Jenkins as President, CEO
09.09.Remembering 9/11 : Emergent employees reflect on the events of September 11th
06.09.Emergent BioSolutions Initiates Phase 1 Study Evaluating Lassa Virus Vaccine Candidate
06.09.Emergent BioSolutions Inc. Initiates Phase 1 Study Evaluating Lassa Virus Vaccine Candi..
31.08.Testing, Treatment, and Vaccines are the Three Ways Companies Can Fight Monkeypox (SKHH..
29.08.Sector Update: Health Care Stocks Moderately Lower in Late Trade
29.08.Chimerix Gets Up to $680 Million US Government Contract for Tembexa Smallpox Treatment;..
15.08.Soligenix Announces Recent Accomplishments And Second Quarter 2022 Financial Results
15.08.Emergent BioSolutions Says FDA Flags Quality Control Issues at Maryland Facility
13.08.Emergent receives FDA warning letter over quality control issues
12.08.Emergent Biosolutions Inc. : Other Events, Financial Statements and Exhibits (form 8-K)
12.08.FDA Issues Warning Letter to Emergent Biosolutions After February Inspection
10.08.Emergent BioSolutions to Participate in Investor Conferences
10.08.Emergent BioSolutions to Participate in Investor Conferences
04.08.How worried should we be about the monkeypox health emergency?
03.08.Emergent Biosolutions : REPORTS FINANCIAL RESULTS FOR SECOND QUARTER 2022 - Form 8-K/A
03.08.EMERGENT BIOSOLUTIONS INC. Results of Operations and Financial Condition, Regulation F..
02.08.Emergent BioSolutions Falls Amid Q2 Net Loss, Revenue Drop
01.08.Emergent Biosolutions : Q2 Earnings Snapshot
01.08.Emergent Biosolutions Swings to Q2 Adjusted Net Loss, Revenue Drops
01.08.Emergent Biosolutions : REPORTS FINANCIAL RESULTS FOR SECOND QUARTER 2022 - Form 8-K
01.08.Emergent Biosolutions Inc. : Results of Operations and Financial Condition, Regulation FD ..
01.08.Tranche Update on Emergent BioSolutions Inc.'s Equity Buyback Plan announced on Novembe..
01.08.Emergent BioSolutions Inc. Provides Earnings Guidance for the Third Quarter and Full Ye..
01.08.Emergent BioSolutions Inc. Reports Earnings Results for the Second Quarter and Six Mont..
01.08.Earnings Flash (EBS) EMERGENT BIOSOLUTIONS Posts Q2 Loss $-0.86
01.08.Earnings Flash (EBS) EMERGENT BIOSOLUTIONS Reports Q2 Revenue $242.7M
01.08.Emergent BioSolutions Reports Financial Results for Second Quarter 2022
01.08.Emergent BioSolutions Reports Financial Results for Second Quarter 2022
01.08.Earnings Reaction History: Emergent Biosolutions Inc, 50.0% Fo..
01.08.North American Morning Briefing:Stock Futures -2-
26.07.Explainer-How worried should we be about the monkeypox global health emergency?
26.07.Explainer-How worried should we be about the monkeypox global health emergency?
26.07.How worried should we be about the monkeypox global health emergency?
25.07.Weber, Newmont fall; WWE, Emergent rise
18.07.Emergent BioSolutions to Release Second Quarter 2022 Financial Results and Conduct Conf..
08.07.Emergent BioSolutions and Ridgeback Biotherapeutics Enter Into Agreement for Ebanga Tre..
08.07.Sector Update: Health Care Stocks Mixed Pre-Bell Friday
07.07.Emergent Biosolutions to Work With Ridgeback Biotherapeutics to Expand Ebola Virus Trea..
07.07.Emergent BioSolutions and Ridgeback Biotherapeutics Enter Into Agreement for Ebanga&tra..
07.07.Emergent BioSolutions and Ridgeback Biotherapeutics Enter Into Agreement for Ebanga..
06.07.Emergent Biosolutions Inc. : Change in Directors or Principal Officers, Regulation FD Disc..
06.07.Emergent BioSolutions Announces Appointment of Sujata Dayal to Board of Directors
06.07.Emergent Biosolutions Announces Appointment of Sujata Dayal to Board of Directors, Memb..
27.06.Emergent BioSolutions Announces FDA Acceptance of Biologics License Application for AV7..
24.06.Sector Update: Health Care Stocks Carried Higher in Friday Trade
24.06.Chimerix Gets $25.3 Million Contract to Supply Tembexa Smallpox Treatment to Canada; Sh..
24.06.Chimerix gets up to $25.3 mln contract from Canada for smallpox drug
24.06.Sector Update: Health Care Stocks Edge Higher Premarket Friday
24.06.Emergent Biosolutions Says FDA Accepts Biologics License Application Review for Anthrax..
24.06.Emergent BioSolutions Announces FDA Acceptance of Biologics License Application for AV7..
24.06.Emergent BioSolutions Announces FDA Acceptance of Biologics License Application for AV7..
24.06.Emergent BioSolutions Announces U.S. Food and Drug Administration Acceptance of Biologi..
24.06.Emergent BioSolutions : FDA to Review AV7909 Anthrax Vaccine Candi..
24.06.US Plans to Approve Bavarian Nordic's Monkeypox Vaccine For Children
23.06.Chimerix Gets $9.3 Million Contract to Supply Tembexa Smallpox Treatment; Shares Rise
23.06.Smallpox drugmakers get new orders as monkeypox spreads
21.06.Emergent BioSolutions Announces Publication of CHIKV VLP Phase 2 Safety and Immunogenic..
21.06.Emergent BioSolutions Announces Publication of CHIKV VLP Phase 2 Safety and Immunogenic..
21.06.Emergent BioSolutions Inc. Announces Publication of CHIKV VLP Phase 2 Safety and Immuno..
10.06.U.S. expects 300,000 more Jynneos doses as monkeypox cases jump to 45
07.06.Emergent Biosolutions Inc. : Termination of a Material Definitive Agreement (form 8-K)
06.06.Emergent Biosolutions Claims Janssen Pharmaceuticals Breached COVID-19 Vaccine Producti..
06.06.Emergent Biosolutions Claims Janssen Pharmaceuticals Breached COVID-19 Vaccine Producti..
Anstehende Termine für EMERGENT BIOSOLUTIONS INC.